GLP-1RA medications, such as those with brand names of Ozempic
and Victoza, don’t put patients with a history of
pancreatitis at increased risk for pancreatitis, and they may
actually lower their risk.
GLP-1RA medications for Type 2 diabetes and obesity may lower risk of acute pancreatitis